130 related articles for article (PubMed ID: 21073472)
21. Novel development of 5-aminolevurinic acid (ALA) in cancer diagnoses and therapy.
Ishizuka M; Abe F; Sano Y; Takahashi K; Inoue K; Nakajima M; Kohda T; Komatsu N; Ogura S; Tanaka T
Int Immunopharmacol; 2011 Mar; 11(3):358-65. PubMed ID: 21144919
[TBL] [Abstract][Full Text] [Related]
22. siRNA-mediated knockdown of the heme synthesis and degradation pathways: modulation of treatment effect of 5-aminolevulinic acid-based photodynamic therapy in urothelial cancer cell lines.
Miyake M; Ishii M; Kawashima K; Kodama T; Sugano K; Fujimoto K; Hirao Y
Photochem Photobiol; 2009; 85(4):1020-7. PubMed ID: 19320847
[TBL] [Abstract][Full Text] [Related]
23. 5-ALA kinetics in meningiomas: analysis of tumor fluorescence and PpIX metabolism in vitro and comparative analyses with high-grade gliomas.
Bunk EC; Wagner A; Stummer W; Senner V; Brokinkel B
J Neurooncol; 2021 Mar; 152(1):37-46. PubMed ID: 33389565
[TBL] [Abstract][Full Text] [Related]
24. Evidence for a bystander role of neutrophils in the response to systemic 5-aminolevulinic acid-based photodynamic therapy.
de Bruijn HS; Sluiter W; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
Photodermatol Photoimmunol Photomed; 2006 Oct; 22(5):238-46. PubMed ID: 16948825
[TBL] [Abstract][Full Text] [Related]
25. Kinetic Evaluation of Determinant Factors for Cellular Accumulation of Protoporphyrin IX Induced by External 5-Aminolevulinic Acid for Photodynamic Cancer Therapy.
Nakanishi T; Ogawa T; Yanagihara C; Tamai I
J Pharm Sci; 2015 Sep; 104(9):3092-100. PubMed ID: 25959076
[TBL] [Abstract][Full Text] [Related]
26. Effects of Silencing Heme Biosynthesis Enzymes on 5-Aminolevulinic Acid-mediated Protoporphyrin IX Fluorescence and Photodynamic Therapy.
Yang X; Li W; Palasuberniam P; Myers KA; Wang C; Chen B
Photochem Photobiol; 2015; 91(4):923-30. PubMed ID: 25809721
[TBL] [Abstract][Full Text] [Related]
27. Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy.
Teng L; Nakada M; Zhao SG; Endo Y; Furuyama N; Nambu E; Pyko IV; Hayashi Y; Hamada JI
Br J Cancer; 2011 Mar; 104(5):798-807. PubMed ID: 21304523
[TBL] [Abstract][Full Text] [Related]
28. Photodynamic effects on nasopharyngeal carcinoma (NPC) cells with 5-aminolevulinic acid or its hexyl ester.
Wu RW; Chu ES; Yow CM; Chen JY
Cancer Lett; 2006 Oct; 242(1):112-9. PubMed ID: 16442708
[TBL] [Abstract][Full Text] [Related]
29. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
[TBL] [Abstract][Full Text] [Related]
30. Radiant near infrared light emitting Diode exposure as skin preparation to enhance photodynamic therapy inflammatory type acne treatment outcome.
Barolet D; Boucher A
Lasers Surg Med; 2010 Feb; 42(2):171-8. PubMed ID: 20166163
[TBL] [Abstract][Full Text] [Related]
31. Photodynamic effectiveness and vasoconstriction in hairless mouse skin after topical 5-aminolevulinic acid and single- or two-fold illumination.
van der Veen N; Hebeda KM; de Bruijn HS; Star WM
Photochem Photobiol; 1999 Dec; 70(6):921-9. PubMed ID: 10628304
[TBL] [Abstract][Full Text] [Related]
32. Sensitivity of normal and malignant human lymphocytes to 5-aminolevulinic acid-mediated photodynamic damage.
Gamaleia NF; Shishko ED; Gluzman DF; Sklyarenko LM
Exp Oncol; 2008 Mar; 30(1):65-9. PubMed ID: 18438344
[TBL] [Abstract][Full Text] [Related]
33. Aminolevulinic acid-mediated photodynamic therapy of human meningioma: an in vitro study on primary cell lines.
El-Khatib M; Tepe C; Senger B; Dibué-Adjei M; Riemenschneider MJ; Stummer W; Steiger HJ; Cornelius JF
Int J Mol Sci; 2015 Apr; 16(5):9936-48. PubMed ID: 25941934
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of Cancer-Specific Protoporphyrin IX Fluorescence by Targeting Oncogenic Ras/MEK Pathway.
Yoshioka E; Chelakkot VS; Licursi M; Rutihinda SG; Som J; Derwish L; King JJ; Pongnopparat T; Mearow K; Larijani M; Dorward AM; Hirasawa K
Theranostics; 2018; 8(8):2134-2146. PubMed ID: 29721068
[TBL] [Abstract][Full Text] [Related]
35. Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer.
Kemmner W; Wan K; Rüttinger S; Ebert B; Macdonald R; Klamm U; Moesta KT
FASEB J; 2008 Feb; 22(2):500-9. PubMed ID: 17875605
[TBL] [Abstract][Full Text] [Related]
36. Synergistic increase in osteosarcoma cell sensitivity to photodynamic therapy with aminolevulinic acid hexyl ester in the presence of hyperthermia.
Yanase S; Nomura J; Matsumura Y; Watanabe Y; Tagawa T
Photomed Laser Surg; 2009 Oct; 27(5):791-7. PubMed ID: 19878029
[TBL] [Abstract][Full Text] [Related]
37. Doxycycline potentiates antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy in malignant peripheral nerve sheath tumor cells.
Lee MJ; Hung SH; Huang MC; Tsai T; Chen CT
PLoS One; 2017; 12(5):e0178493. PubMed ID: 28558025
[TBL] [Abstract][Full Text] [Related]
38. 5-Aminolaevulinic acid-mediated photodynamic therapy in multidrug resistant leukemia cells.
Li W; Zhang WJ; Ohnishi K; Yamada I; Ohno R; Hashimoto K
J Photochem Photobiol B; 2001 Jul; 60(2-3):79-86. PubMed ID: 11470562
[TBL] [Abstract][Full Text] [Related]
39. Predictive biomarkers for 5-ALA-PDT can lead to personalized treatments and overcome tumor-specific resistances.
Mastrangelopoulou M; Grigalavicius M; Raabe TH; Skarpen E; Juzenas P; Peng Q; Berg K; Theodossiou TA
Cancer Rep (Hoboken); 2022 Dec; 5(12):e1278. PubMed ID: 32737955
[TBL] [Abstract][Full Text] [Related]
40. Gefitinib enhances the efficacy of photodynamic therapy using 5-aminolevulinic acid in malignant brain tumor cells.
Sun W; Kajimoto Y; Inoue H; Miyatake S; Ishikawa T; Kuroiwa T
Photodiagnosis Photodyn Ther; 2013 Feb; 10(1):42-50. PubMed ID: 23465372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
